Status:
COMPLETED
Development of the Balance Recovery Falls-Efficacy Scale for the Community-dwelling Older Adults
Lead Sponsor:
Queen Margaret University
Collaborating Sponsors:
Singapore Institute of Technology
Conditions:
Accidental Fall
Aging
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The first phase of the study aims to study the incidence of near-falls. The second phase will be to develop a scale which operationalize balance recovery confidence in the older adults. This study wil...
Detailed Description
This study will progress through two phases The first phase will recruit 30 older adults from ages of 65 and older living in the community. A study administrator will contact the participants daily o...
Eligibility Criteria
Inclusion
- 65-year-old and above
- Ability to read, write and communicate in English
- History of at least one near-fall or one fall within the last 12 months
- Living independently in the community with or without the use of a walking aid
- Not having any cognitive dysfunction by achieving a score of 7 or less in the 6-item cognitive impairment test (6CIT)
- Able to walk 6 meters within 12 seconds by performing the Timed Up and Go (TUG) test
- Able to catch a 30cm ruler by each hands using the ruler drop test
Exclusion
- Requiring any physical assistance from another person to walk within home
- Known active malignant conditions
- Cardiovascular conditions e.g. neurally mediated syncope, cardiac syncope, structural heart diseases e.g. aortic stenosis or hospitalization for myocardial infarction or heart surgery within 3 months
- Pulmonary conditions e.g. serious chronic obstructive pulmonary disease or oxygen dependence
- Musculoskeletal conditions e.g. moderate to severe osteoarthritis that could affect balance control and muscle function e.g. self-reported pain or dysfunction of the trunk and extremities, fractures or injuries in the extremities in the last 6 months
- Neurological conditions such as Parkinson's Disease, sequelae of stroke, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) or severe Dementia or epilepsy
- Legal blindness, severe visual impairment, severe hearing impairment or legal deafness
Key Trial Info
Start Date :
September 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04087551
Start Date
September 11 2019
End Date
September 15 2020
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore Institute of Technology
Singapore, Singapore, 138683